SEC Company Response from Cartesian Therapeutics, Inc. (RNAC) (CIK 0001453687) (RNAC) — Feb 4, 2020
Cartesian Therapeutics, Inc. (RNAC) (CIK 0001453687)
Date: Feb. 4, 2020 · CIK: 0001453687 · Accession: 0001104659-20-010772
AI Filing Summary & Sentiment
File numbers found in text: 333-236147
Letter
February 4, 2020
Via EDGAR Transmission
Securities and Exchange Commission
Division of Corporation Finance
Mail Stop 3010
100 F Street, N.E.
Washington, D.C. 20549
Attention: Irene Paik
Re: SELECTA BIOSCIENCES, INC.
Registration Statement on Form S-3 (Registration No. 333-236147)
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, we hereby request acceleration of the effective date of the Registration Statement on Form S-3 (Registration No. 333-236147) (the “Registration Statement”) of Selecta Biosciences, Inc. (the “Company”). We respectfully request that the Registration Statement become effective as of 4:30 p.m., Eastern Time, on February 6, 2020, or at such later time as the Company or its counsel may orally request via telephone call to the staff. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Latham & Watkins LLP, by calling Peter Handrinos at (617) 948-6060 or Wes Holmes at (617) 948-6027.
If you have any questions regarding the foregoing, please do not hesitate to contact Peter Handrinos at (617) 948-6060 or Wes Holmes at (617) 948-6027, of Latham & Watkins LLP. Thank you in advance for your consideration.
Very truly yours,
SELECTA BIOSCIENCES, INC.
Show Raw Text
CORRESP
1
filename1.htm
February 4, 2020
Via EDGAR Transmission
Securities and Exchange Commission
Division of Corporation Finance
Mail Stop 3010
100 F Street, N.E.
Washington, D.C. 20549
Attention: Irene Paik
Re: SELECTA BIOSCIENCES, INC.
Registration Statement on Form S-3 (Registration No. 333-236147)
Ladies and Gentlemen:
In accordance with
Rule 461 under the Securities Act of 1933, as amended, we hereby request acceleration of the effective date of the Registration
Statement on Form S-3 (Registration No. 333-236147) (the “Registration Statement”) of Selecta Biosciences, Inc.
(the “Company”). We respectfully request that the Registration Statement become effective as of 4:30 p.m., Eastern
Time, on February 6, 2020, or at such later time as the Company or its counsel may orally request via telephone call to the staff.
Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Latham & Watkins
LLP, by calling Peter Handrinos at (617) 948-6060 or Wes Holmes at (617) 948-6027.
If you have any questions regarding the
foregoing, please do not hesitate to contact Peter Handrinos at (617) 948-6060 or Wes Holmes at (617) 948-6027, of Latham &
Watkins LLP. Thank you in advance for your consideration.
Very truly yours,
SELECTA BIOSCIENCES, INC.
By:
/s/ Bradford D. Dahms
Name: Bradford D. Dahms
Title: Chief Financial Officer
cc: Peter N. Handrinos, Latham & Watkins LLP
Wesley C. Holmes, Latham & Watkins LLP